Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 5 of 5 clinical reviews.
Deep-dive into the economic modeling behind the Scandinavian Simvastatin Survival Study (4S), including cost per QALY, payer coverage shifts, and real-world pricing considerations for simvastatin in secondary prevention.
Read clinical reviewA deep dive into the Scandinavian Simvastatin Survival Study (4S) results, covering primary and secondary endpoints, effect sizes, confidence intervals, subgroup analyses, and the time-course pattern of mortality reduction.
Read clinical reviewA detailed plain-English breakdown of the Scandinavian Simvastatin Survival Study (4S), the first randomized trial proving statins reduce death in heart disease patients.
Read clinical reviewA critical deep-dive into the enrollment biases, generalizability gaps, statistical caveats, and conflict-of-interest concerns surrounding the landmark 4S simvastatin trial.
Read clinical reviewHow the Scandinavian Simvastatin Survival Study reshaped secondary prevention guidelines, prescribing patterns, and the standard of care for patients with established coronary heart disease.
Read clinical review